Skip to content

2nd International Survey on Interventional Strategies

2nd International Survey on Interventional Strategies

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04001452
Enrollment
500
Registered
2019-06-28
Start date
2019-07-01
Completion date
2020-01-31
Last updated
2019-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The study aims to evaluate the decision-making pathways of interventional cardiologists, when assessing patients, presented with stable coronary artery disease.

Detailed description

2nd International Survey on Interventional Strategies is a web-based platform. The survey contains specific questions and dedicated case presentations on two major topics. The first part queries the characteristics of the participants, including overall experience in interventional cardiology, annual volume of percutaneous coronary intervention (PCI), and duration of experience with quantitative coronary angiography (QCA), intravascular ultrasound (IVUS),optical coherence tomography (OCT), fractional flow reserve (FFR) and non-hyperaemic pressure ratios (NHPR). The survey uses here predefined categories and single-choice questions. The second part investigates personal strategies for evaluating angiographically intermediate stenoses in the catheterization laboratory. Here, participants are asked to evaluate 5 complete coronary angiograms. All cases are characterised as stable angina without relevant changes on resting ECG. No information about non-invasive testing is known or provided. Here participants are asked to (1) localise all relevant stenoses by indicating the involved segment; (2) define percent diameter stenosis (%DS) by visual estimate; and (3) determine the significance of the stenosis of interest. In cases of angiographic uncertainty, the preferred diagnostic tool is asked to be selected from the arsenal available in the catheterisation laboratory, namely QCA, IVUS, OCT, FFR or NHPR. Participants are asked to make their decisions assuming ideal world conditions, without considering any financial restrictions or local regulations, but only after the best clinical practice achievable in this virtual catheterisation laboratory.

Interventions

None listed

Sponsors

Abbott
CollaboratorINDUSTRY
Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Interventional cardiologists * Interventional cardiologists in training

Design outcomes

Primary

MeasureTime frameDescription
Need for using any additional diagnostic toolOne monthIt will be assessed, how often participants express their desire to use one or other additional diagnostic tool to make a decision about lesion significance

Secondary

MeasureTime frameDescription
Need for using any additional diagnostic tool in different subgroupsOne monthIt will be assessed, how often the different subgroups of participants (i.e. by age, by interventional experience, by experience with different tools) express their desire to use one or other additional diagnostic tool to make a decision about lesion significance
Accuracy of visually estimated lesion severityOne monthVisually estimated diameter stenosis will be compared to quantitatively assessed diameter stenosis

Contacts

Primary ContactGabor G Toth, MD, PhD
gabor.g.toth@medunigraz.at0043 316 385 12544
Backup ContactEmanuele Barbato, MD, PhD
emanuele.barbato@unina.it

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026